Eiko Lifesciences Financials

BSE: 540204

₹45.63

up-down-arrow-0.27 (-0.59%)

As on 11-Sep-2026IST

Market cap

info icon

₹67 Cr

Revenue (TTM)

info icon

₹59 Cr

P/E Ratio

info icon

13.1

P/B Ratio

info icon

1

Div. Yield

info icon

0 %

Income Statement (₹ Cr)

TTM Mar-25 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13 Mar-12
Operating Revenue
58.75
37.66
10.40
4.25
2.34
--
Total Income
59.86
38.38
10.41
4.30
2.43
--
Total Expenditure
50.88
34.90
14.91
4.95
2.02
--
EBITDA
7.87
2.77
-4.51
-0.70
0.32
--
Depreciation
1.02
0.74
0.19
0.17
0.08
--
EBIT
6.85
2.03
-4.70
-0.87
0.24
--
Interest
0.41
0.17
0.24
0.19
0.09
--
Other Income
1.12
0.72
0.01
0.06
0.09
--
Exceptional Items
--
0.34
--
--
--
--
Profit before Tax
7.56
3.06
-4.93
-1.00
0.25
--
Provision for Tax
1.92
0.75
-1.31
-0.21
0.05
--
Profit after Tax
5.64
2.32
-3.62
-0.78
0.20
--
Minority Interest
-0.63
-0.21
1.71
0.34
0.00
--
Share of Associate
0.08
--
--
--
--
--
Consolidated Profit
5.09
2.11
-1.91
-0.44
0.20
--

Liabilities (₹ Cr)

TTM Mar-25 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13 Mar-12
Shareholder's Funds
68.78
56.79
2.95
4.92
5.56
--
Minority Interest
-0.63
0.22
-1.83
-0.12
0.22
--
Non-Current Liabilities
4.17
2.83
-0.02
0.15
0.51
--
Current Liabilities
15.38
6.27
9.33
4.08
4.66
--
Total Liabilities
89.37
66.10
12.05
9.31
10.95
--

Assets (₹ Cr)

TTM Mar-25 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13 Mar-12
Non-Current Assets
41.96
33.22
5.39
4.86
4.98
--
Current Assets
47.41
32.88
5.03
4.17
5.98
--
Total Assets
89.37
66.10
12.05
9.31
10.95
--
Total Debt*
--
2.76
1.61
1.37
1.74
--
Net Current Assets
32.03
26.61
-4.30
0.09
1.32
--
Contingent Liabilities
--
--
--
--
--
--

Cashflow (₹ Cr)

TTM Mar-25 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13 Mar-12
Cash From Operating Activities
--
2.92
-0.33
0.16
--
--
Cash Flow from Investing Activities
--
-11.44
-0.71
-0.30
--
--
Cash from Financing Activities
--
6.96
0.95
-0.55
--
--
Net Cash Inflow / Outflow
--
-1.57
-0.09
-0.69
--
--

Financials Ratios

TTM Mar-25 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13 Mar-12
Adjusted EPS (₹) info
3.62
1.53
-4.32
-1.01
0.45
--
Cash EPS (₹) info
3.47
2.22
-7.78
-1.39
0.64
--
Adjusted Book Value (₹) info
46.33
41.26
6.68
11.17
12.62
--
Dividend per Share (₹) info
--
--
--
--
--
--
Cash Flow per Share (₹) info
--
2.12
-0.85
0.42
--
--
Free Cash Flow per Share (₹) info
--
-5.02
1.60
0.08
0.53
--

Profitability Ratios

TTM Mar-25 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13 Mar-12
ROCE (%) info
--
10.08
-86.53
-11.96
4.56
--
ROE (%) info
7.98
7.76
-92.01
-14.96
3.61
--
ROA (%) info
7.26
6.06
-37.22
-7.85
1.83
--
EBIT Margin (%) info
11.66
5.39
-45.21
-20.52
10.27
--
Net Margin (%) info
9.42
6.04
-34.76
-18.22
8.25
--
Cash Profit Margin (%) info
0.00
8.11
-32.94
-14.44
12.07
--

Growth Ratios

TTM Mar-25 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13 Mar-12
Revenue Growth (%) info
56.13
262.05
145.03
81.65
--
--
EBIT Growth (%) info
124.34
--
-439.80
-462.95
--
--
Net Profit Growth (%) info
116.17
164.05
-361.54
-490.99
--
--
EPS Growth (%) info
82.56
135.39
-328.74
-326.44
--
--
Book Value Growth (%) info
--
1,828.26
-40.19
-11.47
--
--

Valuation Ratios

TTM Mar-25 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13 Mar-12
Price / Earnings info
13.13
34.20
--
--
95.35
--
Price / Book Value info
0.98
1.27
1.32
4.43
3.37
--
Dividend Yield (%) info
--
--
--
--
--
--
EV/EBITDA info
6.45
18.09
-1.21
-35.92
47.43
--
Close Price (₹) info
50.44
52.33
8.80
49.44
42.46
--
High Price (₹) info
65.90
74.88
46.97
63.05
42.94
--
Low Price (₹) info
45.90
42.00
8.80
34.67
17.16
--
Market Cap (₹ Cr) info
66.85
72.02
3.88
21.79
18.72
--

Solvency Ratios

TTM Mar-25 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13 Mar-12
Debt to Equity info
0.04
0.05
0.55
0.28
0.31
--
Short term debt to equity ratio info
0.02
0.01
--
0.19
0.23
--
Current Ratio info
3.08
5.25
0.54
1.02
1.28
--
Quick Ratio info
2.82
4.33
0.19
0.46
0.62
--
Interest Coverage info
19.34
19.55
-19.34
-4.39
3.82
--

Operating Efficiency Ratios

TTM Mar-25 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13 Mar-12
Debtors to sales (%) info
34.42
28.64
11.33
20.28
62.60
--
Asset Turnover info
0.76
0.98
1.07
0.42
0.21
--
Receivable days info
--
57.98
35.79
99.91
228.50
--
Inventory Days info
--
43.54
96.92
232.74
484.30
--
Payable days info
--
40.04
125.83
219.36
607.63
--
Cash Conversion Cycle info
--
61.48
6.89
113.29
105.17
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...